Viamet Pharmaceuticals Garners $5,000,000 New Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e2674a2a-3290-483d-8c1a-48f0576c513a
Date
12/31/2013
Company Name
Viamet Pharmaceuticals
Mailing Address
4505 Emperor Blvd. Durham, NC 27703 USA
Company Description
Viamet Pharmaceuticals discovers and develops best-in-class inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, our Metallophile Technology.
Website
http://www.viamet.com
Transaction Type
Venture Equity
Transaction Amount
$5,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Venture Investor